埃博拉病毒的有效化学灭活
Effective Chemical Inactivation of Ebola Virus.
作者信息
Haddock Elaine, Feldmann Friederike, Feldmann Heinz
出版信息
Emerg Infect Dis. 2016 Jul;22(7):1292-4. doi: 10.3201/eid2207.160233. Epub 2016 Jul 15.
Abstract
Reliable inactivation of specimens before removal from high-level biocontainment is crucial for safe operation. To evaluate efficacy of methods of chemical inactivation, we compared in vitro and in vivo approaches using Ebola virus as a surrogate pathogen. Consequently, we have established parameters and protocols leading to reliable and effective inactivation.
摘要
在从高级生物防护设施中取出标本之前进行可靠的灭活对于安全操作至关重要。为了评估化学灭活方法的效果，我们使用埃博拉病毒作为替代病原体比较了体外和体内方法。因此，我们建立了能够实现可靠且有效灭活的参数和方案。
相似文献
1
Effective Chemical Inactivation of Ebola Virus.
Emerg Infect Dis. 2016 Jul;22(7):1292-4. doi: 10.3201/eid2207.160233. Epub 2016 Jul 15.
2
Development and Testing of a Method for Validating Chemical Inactivation of Ebola Virus.
Viruses. 2018 Mar 13;10(3):126. doi: 10.3390/v10030126.
3
Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.
J Clin Microbiol. 2015 Oct;53(10):3148-54. doi: 10.1128/JCM.01449-15. Epub 2015 Jul 15.
4
Evaluation of the inactivation effect of Triton X-100 on Ebola virus infectivity.
J Clin Virol. 2017 Jan;86:27-30. doi: 10.1016/j.jcv.2016.11.009. Epub 2016 Nov 22.
5
Efficacy of microbicides for inactivation of Ebola-Makona virus on a non-porous surface: a targeted hygiene intervention for reducing virus spread.
Sci Rep. 2020 Sep 17;10(1):15247. doi: 10.1038/s41598-020-71736-x.
6
Effectiveness of Four Disinfectants against Ebola Virus on Different Materials.
Viruses. 2016 Jul 7;8(7):185. doi: 10.3390/v8070185.
7
Inactivation Validation of Ebola, Marburg, and Lassa Viruses in AVL and Ethanol-Treated Viral Cultures.
Viruses. 2024 Aug 24;16(9):1354. doi: 10.3390/v16091354.
8
[The effect of some physical and chemical factors on inactivation of the Ebola virus].
Vopr Virusol. 1995 Mar-Apr;40(2):74-6.
9
Effectiveness of Dettol Antiseptic Liquid for Inactivation of Ebola Virus in Suspension.
Sci Rep. 2019 Apr 29;9(1):6590. doi: 10.1038/s41598-019-42386-5.
10
Efficacy of disinfectants for inactivation of Ebola virus in suspension by integrated cell culture coupled with real-time RT-PCR.
J Hosp Infect. 2022 Jul;125:67-74. doi: 10.1016/j.jhin.2022.04.008. Epub 2022 Apr 25.
引用本文的文献
1
Harnessing Hazara Virus as a Surrogate for Crimean-Congo Hemorrhagic Fever Virus Enables Inactivation Studies at a Low Biosafety Level.
Pathogens. 2025 Jul 15;14(7):700. doi: 10.3390/pathogens14070700.
2
Thermal tolerance and inactivation of Ebola virus.
Virol Sin. 2025 Aug;40(4):669-671. doi: 10.1016/j.virs.2025.07.004. Epub 2025 Jul 9.
3
Successful Inactivation of High-Consequence Pathogens in PrimeStore Molecular Transport Media.
Viruses. 2025 Apr 29;17(5):639. doi: 10.3390/v17050639.
4
Enhancing safety of rapid and accurate malaria diagnosis in patients at risk for viral haemorrhagic fever.
Malar J. 2025 Apr 23;24(1):133. doi: 10.1186/s12936-025-05377-8.
5
Multi-platform omics analysis of Nipah virus infection reveals viral glycoprotein modulation of mitochondria.
Cell Rep. 2025 Mar 25;44(3):115411. doi: 10.1016/j.celrep.2025.115411. Epub 2025 Mar 17.
6
Inactivation Validation of Ebola, Marburg, and Lassa Viruses in AVL and Ethanol-Treated Viral Cultures.
Viruses. 2024 Aug 24;16(9):1354. doi: 10.3390/v16091354.
7
Mapping of susceptibility loci for Ebola virus pathogenesis in mice.
Cell Rep. 2024 May 28;43(5):114127. doi: 10.1016/j.celrep.2024.114127. Epub 2024 Apr 21.
8
A Bivalent Adenovirus-Vectored Vaccine Induces a Robust Humoral Response, but Does Not Protect Cynomolgus Macaques Against a Lethal Challenge With Sudan Virus.
J Infect Dis. 2024 Nov 15;230(5):1083-1092. doi: 10.1093/infdis/jiae056.
9
Preservation of scRNA-Seq Libraries Using Existing Inactivation Protocols.
Pathogens. 2024 Feb 13;13(2):167. doi: 10.3390/pathogens13020167.
10
Sex differences and individual variability in the captive Jamaican fruit bat (Artibeus jamaicensis) intestinal microbiome and metabolome.
Sci Rep. 2024 Feb 9;14(1):3381. doi: 10.1038/s41598-024-53645-5.
本文引用的文献
1
Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain.
Emerg Infect Dis. 2015 Oct;21(10):1777-83. doi: 10.3201/eid2110.150259.
2
Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.
J Clin Microbiol. 2015 Oct;53(10):3148-54. doi: 10.1128/JCM.01449-15. Epub 2015 Jul 15.
3
Effects of a plasma heating procedure for inactivating Ebola virus on common chemical pathology tests.
Hong Kong Med J. 2015 Jun;21(3):201-7. doi: 10.12809/hkmj144373. Epub 2015 Apr 23.
4
In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein.
J Infect Dis. 2007 Nov 15;196 Suppl 2:S313-22. doi: 10.1086/520590.
5
A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.
J Infect Dis. 1998 Sep;178(3):651-61. doi: 10.1086/515386.
6
Inactivation of Ebola virus with 60Co irradiation.
J Infect Dis. 1981 Feb;143(2):291. doi: 10.1093/infdis/143.2.291.
7
Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation.
J Clin Microbiol. 1982 Oct;16(4):704-8. doi: 10.1128/jcm.16.4.704-708.1982.
8
Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses.
J Clin Microbiol. 1984 Sep;20(3):486-9. doi: 10.1128/jcm.20.3.486-489.1984.
Zotero 插件